Passage Bio, Inc. (PASG)

USD 0.36

(-0.53%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 3.72 Million 3.67 Million 1.54 Million 800 Thousand 134 Thousand -
Gross Profit -3.72 Million -3.67 Million -1.54 Million -800 Thousand -134 Thousand -
Operating Expenses 108.38 Million 135.39 Million 177.72 Million 111.9 Million 36.68 Million 10.09 Million
Selling, General and Administrative Expenses 41.58 Million 49.34 Million 60.05 Million 30.11 Million 6.95 Million 928 Thousand
Research and Development Expenses 61.41 Million 86.05 Million 117.67 Million 81.78 Million 29.73 Million 9.16 Million
Other Expenses 5.39 Million - - - - -
Cost and Expenses 108.38 Million 135.39 Million 177.72 Million 111.9 Million 36.68 Million 10.09 Million
Operating Income -108.38 Million -138.39 Million -185.72 Million -112.9 Million -37.18 Million -13.46 Million
Interest Expense - 2.26 Million - - - -
Income Tax Expense - 731 Thousand 6.11 Million -470 Thousand 8.94 Million -696 Thousand
Earnings before Tax -102.06 Million -136.12 Million -185.38 Million -112.23 Million -45.63 Million -12.77 Million
Net Income -102.06 Million -136.85 Million -191.5 Million -111.76 Million -54.57 Million -12.77 Million
Earnings Per Share Basic -1.86 -2.51 -3.59 -2.89 -1.19 -0.53
Earnings Per Share Diluted -1.86 -2.51 -3.59 -2.89 -1.19 -0.53
Weighted Average Shares Outstanding 54.74 Million 54.42 Million 53.34 Million 38.61 Million 45.79 Million 23.96 Million
Weighted Average Shares Outstanding (Diluted) 54.74 Million 54.42 Million 53.34 Million 38.61 Million 45.79 Million 23.96 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -98.34 Million -138.39 Million -185.72 Million -112.9 Million -36.55 Million -12.77 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts